Design and Baseline Data from Hephaistos Study Evaluating Efficacy and Safety of Early Initiation of Everolimus With Reduced Tacrolimus in De Novo Liver Transplant Recipients

被引：0

作者：

Nashan, Bjorn ^{[1
]}

Schemmer, Peter ^{[1
]}

Braun, Felix ^{[1
]}

Dworak, Markus ^{[1
]}

Wimmer, Peter ^{[1
]}

Schlitt, Hans ^{[1
]}

机构：

[1] Hephaistos Study Grp, Nurnberg, Germany

来源：

TRANSPLANTATION | 2015年 / 99卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

P-270

引用

页码：214 / 215

页数：2

共 50 条

[21] EFFICACY AND SAFETY OF EVEROLIMUS IN COMBINATION WITH REDUCED TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: 36-MONTH RESULTS FROM THE RANDOMIZED H2304 STUDY
Saliba, F.
Duvoux, C.
Durand, F.
Neau-Cransac, M.
Hardwigsen, J.
Pageaux, G.
Di Giambattista, F.
TRANSPLANT INTERNATIONAL, 2015, 28 : 18 - 18
[22] The H2304E1 Study: Efficacy and Safety of Everolimus With Reduced Tacrolimus Versus Standard Tacrolimus in De Novo Liver Transplant Recipients at 36 Months.
De Simone, P.
Kaiser, G. M.
De Carlis, L.
Metselaar, H. J.
Duvoux, C.
Nevens, F.
Fischer, L.
Fung, J.
Dong, G.
Rauer, B.
Junge, G.
Saliba, F.
LIVER TRANSPLANTATION, 2014, 20 : S106 - S106
[23] Efficacy and Safety of Everolimus With Reduced Tacrolimus in De Novo Liver Transplant Recipients: Long-Term Results From the H2304E1 Study.
Duvoux, C.
Saliba, F.
Kaiser, G.
De Carlis, L.
Metselaar, H.
De Simone, P.
Nevens, F.
Fischer, L.
Fung, J.
Dong, G.
Rauer, B.
Junge, G.
AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 710 - 710
[24] Efficacy and Safety of Everolimus With Reduced Tacrolimus in De Novo Liver Transplant Recipients: Long-Term Results From the H2304E1 Study.
Duvoux, C.
Saliba, F.
Kaiser, G.
De Carlis, L.
Metselaar, H.
De Simone, P.
Nevens, F.
Fischer, L.
Fung, J.
Dong, G.
Rauer, B.
Junge, G.
TRANSPLANTATION, 2014, 98 : 710 - 710
[25] Delayed Introduction of Everolimus Versus Tacrolimus in de Novo Liver Transplant Recipients: Safety Events of Interest with Everolimus Use
Fischer, L.
Chavin, K.
Huang, M. A.
Kozlowski, T.
Dong, G.
Lopez, P.
Junge, G.
De Carlis, L.
TRANSPLANTATION, 2012, 94 (10) : 48 - 48
[26] Everolimus with Early Reduction or Elimination of Tacrolimus in 719 De Novo Liver Transplant Recipients-12 Month Efficacy and Safety Results from H2304 Study
Fung, J.
Nevens, F.
De Carlis, L.
Metselaar, H. J.
Beckebaum, S.
Saliba, F.
Jonas, S.
Sudan, D.
Fischer, L.
Duvoux, C.
Chavin, K. D.
Koneru, B.
Jiang, H.
Hexham, J. M.
Junge, G.
De Simone, P.
AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 28 - 28
[27] EVEROLIMUS WITH REDUCED TACROLIMUS VERSUS STANDARD TACROLIMUS IN LIVING-DONOR LIVER TRANSPLANT RECIPIENTS: BASELINE DATA FROM THE H2307 STUDY
Lopez, Patricia
Levy, Gary
Jeng, Long-Bin
Suh, Kyung Suk
Joo, Dong Jin
Lee, Sung Gyu
Lee, Wei-Chen
Chen, Chao-Long
Soin, Arvinder Singh
Joh, Jae Won
Yoshizumi, Tomoharu
Grant, David
Martzloff, El-Djouher
Sips, Carole
Wang, Zailong
TRANSPLANT INTERNATIONAL, 2015, 28 : 459 - 459
[28] EFFICACY AND SAFETY OF EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS IN 719 DE NOVO LIVER TRANSPLANT RECIPIENTS: 12 MONTH RESULTS OF A PHASE III, RANDOMIZED, CONTROLLED STUDY
Saliba, Faouzi
De Simone, Paolo
Nevens, Frederik
De Carlis, Luciano
Metselaar, Herold
Beckebaum, Susanne
Jonas, Sven
Sudan, Debra
Fischer, Lutz
Fung, John J.
Jiang, Hai
Junge, Guido
HEPATOLOGY, 2011, 54 : 1430A - 1431A
[29] EVEROLIMUS WITH REDUCED TACROLIMUS VERSUS STANDARD TACROLIMUS IN LIVING-DONOR LIVER TRANSPLANT RECIPIENTS: BASELINE DATA FROM THE H2307 STUDY
Settmacher, U.
Braun, F.
Sips, C.
Dong, G.
Kroeger, I.
Sanchez, J. Aguilar
TRANSPLANT INTERNATIONAL, 2015, 28 : 32 - 32
[30] Efficacy and Safety of Everolimus Based Immunosuppression in HCV Positive De Novo Liver Transplant Recipients
Saliba, F.
De Simone, P.
De Carlis, L.
Metselaar, H. J.
Beckebaum, S.
Jonas, S.
Sudan, D.
Fung, J.
Fischer, L.
Huang, M. A.
Foltys, D.
Wang, Y.
Sips, C.
Lopez, P.
Nevens, F.
AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 125 - 126

← 1 2 3 4 5 →